Skip to main content

Day: June 5, 2025

America’s Car-Mart, Inc. Schedules Fourth Quarter Fiscal Year 2025 Results and Conference Call

ROGERS, Ark., June 05, 2025 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2025 fourth quarter financial results on Thursday, June 12, 2025, before the market opens. A webcast and conference call will be held that same day at 9:00 a.m. ET to review the Company’s results. Participants may access the conference call via webcast using this link: Webcast Link Here. To participate via telephone, please register in advance using this Registration Link. Upon registration, all telephone participants will receive a one-time confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call. All participants are encouraged to dial-in 10 minutes prior to the start time. A replay of the conference call and...

Continue reading

TOMI Announces Appointment of David Vanston as Chief Financial Officer

FREDERICK, Md., June 05, 2025 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the appointment of Mr. David Vanston as Chief Financial Officer, effective May 30, 2025. Mr. Vanston brings more than 25 years of international financial leadership experience across the life sciences, manufacturing, and technology sectors. He has held senior finance roles at both private equity-backed and publicly traded companies, including CFO positions at Jon-Don, Flexan, Arcmed-Diba Industries, and VolitionRx. Over his career, he has led global finance organizations and played a key role in strategic planning, financial reporting, and operational efficiency. Mr. Vanston holds an MBA from Warwick University and is a Fellow of...

Continue reading

Rio2 Announces 2025 AGM Results

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) announces the results of voting at its Annual and Special General Meeting of Shareholders (the “Meeting”) held June 4, 2025. A total of 238,282,608 common shares were voted, representing 55.82% of 426,846,684 shares issued and outstanding as of the record date of the Meeting. Shareholders voted in favour of all items of business before the Meeting, including the election of all director nominees as follows:  VOTES FOR % VOTES FOR VOTESWITHHELD % VOTESWITHHELDKlaus Zeitler 202,502,363 98.43% 3,220,900 1.57%Alex Black 205,702,663 99.99% 20,600 0.01%Andrew Cox 205,701,839 99.99% 21,424 0.01%Ram Ramachandran 205,720,439 100.00% 2,824 0.00%Albrecht Schneider 205,701,939 99.99% 21,324 0.01%Sidney...

Continue reading

IperionX Awarded U.S. Department of Defense SBIR Phase III Contract for Up to US$99M

Low-Cost Domestic Titanium for Defense Applications: Receipt of an SBIR Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) contract to achieve “Low-Cost Domestic Titanium for Defense Applications” in the U.S. SBIR phase III contract: Enables IperionX to receive task order funding from U.S. Department of Defense (DoD) agencies up to a total of US$99 million Accelerating commercial deployment: SBIR Phase III contracts are reserved for technologies ready to transition from R&D into scaled production for U.S. Government use Strategic initial projects: Initial task orders will focus on manufacturing high-performance titanium fasteners for U.S. DoD agenciesCHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) — IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce that is has been awarded a Small Business...

Continue reading

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additions to the Russell Microcap® Index, as published by FTSE Russell on Friday, May 23, 2025. The newly reconstituted indexes are expected to take effect after U.S. market close on Friday, June 27, 2025, and be part of the 2025 Russell indexes reconstitution when the U.S. market opens on Monday, June 30, 2025. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Wednesday, April 30, 2025, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and...

Continue reading

CISO Global Successfully Completes SOC 2 Audit — Third Consecutive Year Marks Continued Commitment to Security and Trust

Scottsdale, AZ, June 05, 2025 (GLOBE NEWSWIRE) — CISO Global Inc. (NASDAQ: CISO), an industry leader in AI-powered security software, managed cybersecurity services, and compliance solutions, today announced its successful completion of its SOC 2 Type II examination. The audit, which reviewed a 12-month period, was conducted by A-LIGN—a trusted cybersecurity compliance firm serving over 4,000 organizations worldwide. The successful audit validates that CISO Global’s data privacy practices and security controls meet the highest standards in the industry. “We are incredibly proud to have successfully completed our SOC 2 audit for the third year in a row,” said CEO, David Jemmett. “This is an achievement that reflects our unwavering commitment to security, trust, and operational excellence. The work from our compliance team...

Continue reading

Pulse Oil Corp. Announces Facility Agreements Totaling $2,250,000

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) — Pulse Oil Corp. (“Pulse” or the “Company”) (TSXV: PUL) is pleased to announce that Pulse has entered into two loan Facility Agreements (the “Facility Agreements”) with related parties to the Company (the “Lenders”), whereby the Lenders have agreed to loan to the Company (collectively, the “Loans”), in aggregate, the sum of $2,250,000 (the “Principal”). Pursuant to the Facility Agreements, the Loans will be made available in tranches of $1,125,000 primarily to fund the Bigoray EOR project’s solvent injection program. The Facility Agreements provide that the principal bears interest at the rate of 15% per annum (the “Interest Rate”), compounded monthly, with fixed partial interest payments being made on a quarterly basis starting on September 30, 2025 in the amount...

Continue reading

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Catches Wall Street’s Attention, Offers Sustainable Way to Gain Exposure to Gold

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) — via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio @IBN , a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Wall Street Targets Breakout Gold Producers as Bull Market Accelerates,” please visit: https://IBN.fm/RtMP5 With gold soaring past $3,000 per ounce in May 2025 — outperforming NASDAQ, the S&P 500, and even bitcoin — Wall Street’s attention is shifting. As U.S. debt-to-GDP climbs above 120% and real interest rates remain negative, gold continues to prove itself as the market’s most dependable...

Continue reading

Cibus, Inc. Announces Pricing of $27.5 Million Public Offering

SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced the pricing of its previously announced public offering of 15,714,285 shares of its Class A Common Stock, at a purchase price of $1.75 per share, including to institutional and strategic investors, as well as the Chairman of Cibus’ board of directors (5,714,286 shares). All of the shares of Class A Common Stock in the offering will be sold by Cibus. The gross proceeds of the offering are expected to be approximately $27.5 million before deducting placement agent fees and other estimated offering expenses payable by the Company. The offering is expected...

Continue reading

Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment

HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal disease Osteoporosis is a common progressive bone disease among adults over 50 years of age that causes bones to weaken, leading to fractures The software provides automated quantification of vertebral parameters from routine CT scans, delivering consistent and objective data to support physician evaluation, before life-altering fractures occurPETACH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd, has received EU MDR CE (Conformité Européenne) mark certification for HealthOST, an SaMD (Software...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.